$35 million in capital is a breath of fresh air for Yardley's OptiNose
Yardley's OptiNose has received $35 million in new capital to continue development of its treatment for serious chronic nasal inflammatory diseases (CNID).
Yardley's OptiNose has received $35 million in new capital to continue development of its treatment for serious chronic nasal inflammatory diseases (CNID).
Last week, the latest class of startups entered DreamIt Ventures' tech accelerator. These fledgling entrepreneurs could be building the next billion-dollar company or learning to fail fast -- the next 90 days will say a lot.
Harrisburg is getting ready to roll up its sleeves once again at the 2014 Harrisburg Startup Week, aimed at boosting the tech scene in Central Pennsylvania.
A couple of New Jersey entrepreneurs came to PA to launch their company, a developer of blood tests for chemotherapy.
Two overseas companies are establishing a U.S. presence in Philadelphia as part of the first class at the University City Science Center's new Digital Health Accelerator (DHA).
On a recent road trip, Keystone Edge sat down with five companies to talk 'what's next,' both for these innovative enterprises and the Lehigh Valley startup economy as a whole.
BFTP/SEP announced it had approved $6.6 million in investments in 37 companies across the region in fiscal year 2014.
The latest funding round from Ben Franklin Technology Partners of Northeastern Pennsylvania will help boost growing companies.
Last month, Keystone Edge hit the road again, visiting Ben Franklin TechVentures on the Lehigh University Campus.
The Jump Start Grant is accepting applications from early stage therapeutic companies in Pennsylvania.